Insider Stock Trading History of Friedman Charlene A


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Friedman Charlene A since year 2005. The trader's CIK number is 1413748. At the time of this reporting, Friedman Charlene A is the VP President, Gen Counsel &Sec of Map Pharmaceuticals, Inc. . (stock ticker symbol MAPP). See this page for all insider trading activities at Map Pharmaceuticals, Inc. .


Stock purchases, sales, and option exercises reported by insider Friedman Charlene A since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-01-25 MAPP Map Pharmaceuticals, Inc. Option Ex 2,750 .00 0
2013-01-26 MAPP Map Pharmaceuticals, Inc. Option Ex 2,250 .00 0
2012-03-09 MAPP Map Pharmaceuticals, Inc. Option Ex 10,000 12.37 123,720
2012-03-09 MAPP Map Pharmaceuticals, Inc. Sale 10,000 17.50 175,000
2012-01-26 MAPP Map Pharmaceuticals, Inc. Option Ex 2,250 .00 0
2010-12-20 MAPP Map Pharmaceuticals, Inc. Option Ex 3,120 10.37 32,354
2010-12-20 MAPP Map Pharmaceuticals, Inc. Sale 3,120 15.50 48,360
2010-10-27 MAPP Map Pharmaceuticals, Inc. Option Ex 7,800 10.37 80,886
2010-10-27 MAPP Map Pharmaceuticals, Inc. Sale 7,800 15.52 121,095
2010-05-13 MAPP Map Pharmaceuticals, Inc. Sale 1,560 17.07 26,633
2010-05-13 MAPP Map Pharmaceuticals, Inc. Option Ex 1,560 10.37 16,177
2010-04-26 MAPP Map Pharmaceuticals, Inc. Option Ex 10,155 10.37 105,307
2010-04-26 MAPP Map Pharmaceuticals, Inc. Sale 10,155 18.03 183,064
2010-04-14 MAPP Map Pharmaceuticals, Inc. Option Ex 1,560 10.37 16,177
2010-04-14 MAPP Map Pharmaceuticals, Inc. Sale 1,560 16.05 25,041

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Friedman Charlene A (VP President, Gen Counsel &Sec of Map Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.